STAT+: Health tech funding is down. Here’s what investors make of the market

"At the earliest stages, there is tremendous upside to be had by investing at reasonable valuations relative to what was starting to seem normal," said @DeenaShakir.

In 2021, funding for health technology companies went on a tear and by July, a rush of mega-deals over $100 million had pushed the total investment to a record-breaking level. The headline from Rock Health’s mid-year funding report said it all: “Another blockbuster year…in six months.”

Things have changed, but investors cautioned that it’s not as bad as it looks.

Continue to STAT+ to read the full story…